Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
Clinical trial NCT04061421 · RECRUITING
Trial details
- NCT number
- NCT04061421
- Sponsor
- Michael Savona
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2027-08-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.